Reuters: Technology News: Thermo Fisher profit tops Street view as Life deal awaits

Reuters: Technology News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

Thermo Fisher profit tops Street view as Life deal awaits Apr 24th 2013, 10:28 Tweet Share this Email Print Related News Broadcom eyes more smartphone chip sales Tue, Apr 23 2013 Lockheed profit beats view; budget cuts hit sales outlook Tue, Apr 23 2013 Celestica expects revenue to improve in current quarter Tue, Apr 23 2013 Xerox focuses on services as printer business declines Tue, Apr 23 2013 Caterpillar misses, cuts view, but says mining has bottomed Mon, Apr 22 2013 A view shows the headquarters of Life Technologies Corp in Carlsbad, California April 15, 2013. Credit: Reuters/Mike Blake Wed Apr 24, 2013 6:28am EDT (Reuters) - Laboratory equipment maker Thermo Fisher Scientific Inc, which this month agreed to acquire Life Technologies Inc, on Wednesday reported a higher-than-expected first-quarter profit, helped by a 10 percent rise in specialty diagnostics sales. Excluding one-time items, Thermo Fisher posted earnings of $1.37 per share. Analysts on average expected $1.29 per share, according to Thomson Reuters I/B/E/S. The world's largest maker of laboratory equipment and scientific instruments reported a net profit from continuing operations of $340.8 million, or 94 cents per share, compared with a profit of $280.8 million, or 76 cents per share, a year earlier. The company raised the low end of its full-year revenue view and lowered its 2013 earnings per share forecast to reflect its decision to suspend share buybacks as it prepares to pay for Life Tech. Thermo Fisher now expects adjusted earnings of $5.27 to $5.39 per share, down from its prior view of $5.32 to $5.46 per share. It expects 2013 revenue of $12.84 billion to $13 billion. The low end of the previously announced range was $12.80 billion. Analysts were looking for earnings of $5.40 per share and revenue of $12.96 billion. Revenue for the quarter rose 4 percent to $3.19 billion, roughly in line with Wall Street estimates of $3.17 billion. The $13.6 billion Life Tech acquisition, which will give Thermo Fisher a major presence in advanced genetic testing, is expected to close in early 2014. Sales from the Analytical Technologies unit fell to $978 million from $980 million a year ago, possibly reflecting the impact of automatic U.S. budget cuts known as sequestration, which hurts academic and government research customers. Specialty Diagnostics saw sales rise 10 percent to $806 million, while sales from the Laboratory Products and Services unit rose 5 percent to $1.54 billion. (Reporting by Bill Berkrot; Editing by Sriraj Kalluvila) Tweet this Link this Share this Digg this Email Reprints We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of Reuters. For more information on our comment policy, see http://blogs.reuters.com/fulldisclosure/2010/09/27/toward-a-more-thoughtful-conversation-on-stories/ Comments (0) Be the first to comment on reuters.com. Add yours using the box above.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions